Back to SRPT overview

SRPT Sarepta Therapeutics PE ratio, current and historical analysis

As of Sep 11, 2024, the Sarepta Therapeutics stock's PE ratio is 171.19. This results from the current EPS of $0.75 and stock price of $128.39.

SRPT PE ratio history

How has SRPT's PE ratio performed in the past
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

Sarepta Therapeutics PE ratio by year

Year PE ratio Change
2023 N/A N/A
2022 N/A N/A
2021 N/A N/A
2020 N/A N/A
2019 N/A N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

SRPT average PE ratio chart

What is the average PE ratio of SRPT for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

SRPT PE vs peers

What is SRPT's PE ratio compared to its peers

Compared to its peer stock GILD, SRPT's PE ratio stands higher.

Stock name PE ratio Market cap
GILD Gilead Sciences Inc 97.84 $103.53B
SRPT Sarepta Therapeutics Inc 167.12 $11.95B
NVAX Novavax Inc N/A $1.91B
PTCT Ptc Therapeutics Inc N/A $2.52B
BCRX Biocryst Pharmaceuticals Inc N/A $1.6B
ALNY Alnylam Pharmaceuticals Inc N/A $33.6B
RNA Avidity Biosciences Inc N/A $4.54B
INSM INSMED Inc N/A $12.7B

Frequently asked questions

What is Sarepta Therapeutics's PE ratio?

The price to earnings ratio for SRPT stock is 171.19 as of Sep 11, 2024.

Why is Sarepta Therapeutics's PE ratio so high?

A company with a higher PE ratio may indicate that the market has higher growth expectations for the company's future earnings or profitability.

How is SRPT's PE ratio calculated (Sarepta Therapeutics PE ratio formula)?

You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Sep 11, 2024), Sarepta Therapeutics's stock price is $128.39. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $0.75. Therefore, Sarepta Therapeutics's P/E ratio for today is 171.19. PE RATIO(171.19) = STOCK PRICE($128.39) / TTM EPS($0.75)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.